Currently, my research area focuses on the identification of better diagnostic and prognostic markers for type 2 diabetes and its complications especially Diabetic kidney disease (DKD). Despite significant advances in metabolic and high blood pressure control, the prevalence and incidence rate of diabetes and DKD is increasing worldwide. Given the overwhelming burden of diabetes and its complication, it is of particular importance to understand the development and progression of diabetes and DKD and to identify new therapeutic approaches which alone or in combination with standard therapy have the potential to prevent or delay its progression thereby improving patient survival. With advances in omics-driven technologies that allow high-throughput measurements of omics-related traits in combination with more sophisticated bioinformatic and statistical methods, we envision for identification of novel diagnostic and prognostic markers for the early diagnosis, prevention and better treatment for diabetes and DKD.
Biography Updated on 2 March 2015